RE

Robyn Elliott

Polynovo Limited | Non-Executive Director
Dr Elliott until recently, was Global Head, Strategic Portfolio Management at CSL Behring, a role that is responsible for governance oversight and business value delivery from a multi-billion-dollar capital expansion portfolio. Dr Elliott previously held Strategic Expansion and Quality Senior Director roles within CSL, was the Managing Director at IDT Australia and commenced her career at DBL Faulding. Dr Elliott has a track record in product development, clinical trials, regulatory affairs, audits, quality management, project management and operational strategy. Her worldwide experience in new facility delivery, production scale up, strategy, regulatory affairs and audit will be invaluable to PolyNovo as the company scales its operations globally. Dr Elliott was a member of the Risk committee.

Company and Role

Company
Title
Tenure
Since
PNV
Polynovo Limited
  • Non-Executive Director
6yrs, 7mthOct 2019

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PNV
Polynovo Limited
17/09/2594,789N/AN/AN/A
30/06/23N/AN/A250,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PNV
Polynovo Limited
17/09/25
Buy
20,000$1.600$32,000On-market trade
PNV
Polynovo Limited
31/10/23
Buy
32,000$1.190$38,080On-market trade
PNV
Polynovo Limited
28/06/23
Buy
27,000$1.470$39,690On-market trade
PNV
Polynovo Limited
16/02/23
Buy
15,789$1.900$29,999Placement
24/11/22
Issued
250,000$0.410$102,476Issue of options